ADVERTISEMENT
Bulk Drugs Makers Set For A New Phase Of Growth
API makers may continue to dominate the pharmaceutical sector in the near future. Here’s why.
19 Jun 2021, 09:37 AM IST
The makers of pharma ingredients have announced capacity expansion as demand rose during the pandemic and India pushed to cut reliance on Chinese supply.Companies including Divi's Laboratories Ltd., Laurus Labs Ltd. and Aarti Drugs Ltd. have set aside capex for expansion in the ongoing fiscal.Active pharma ingredient makers gained “tremendous momentum” during the pandemic, Neel Fofaria, partner at pharma consultant MP Advisors, told ...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Free
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT